OrbusNeich Medical Group Holdings Future Growth
Future criteria checks 2/6
OrbusNeich Medical Group Holdings is forecast to grow earnings and revenue by 7.6% and 12.7% per annum respectively. EPS is expected to grow by 2.6% per annum. Return on equity is forecast to be 10.6% in 3 years.
Key information
7.6%
Earnings growth rate
2.6%
EPS growth rate
Medical Equipment earnings growth | 40.3% |
Revenue growth rate | 12.7% |
Future return on equity | 10.6% |
Analyst coverage | Low |
Last updated | 16 Feb 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 234 | 44 | N/A | N/A | 1 |
12/31/2025 | 204 | 51 | 48 | 54 | 3 |
12/31/2024 | 176 | 44 | 41 | 48 | 3 |
12/31/2023 | 152 | 41 | 30 | 33 | 3 |
6/30/2023 | 149 | 36 | 18 | 22 | N/A |
3/31/2023 | 143 | 27 | 19 | 23 | N/A |
12/31/2022 | 137 | 18 | 20 | 23 | N/A |
9/30/2022 | 132 | 9 | 19 | 22 | N/A |
6/30/2022 | 128 | 0 | 18 | 20 | N/A |
3/31/2022 | 122 | -2 | 18 | 20 | N/A |
12/31/2021 | 116 | -4 | 18 | 20 | N/A |
12/31/2020 | 88 | 7 | 9 | 13 | N/A |
12/31/2019 | 96 | 7 | -1 | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6929's forecast earnings growth (7.6% per year) is above the savings rate (2%).
Earnings vs Market: 6929's earnings (7.6% per year) are forecast to grow slower than the Hong Kong market (12.4% per year).
High Growth Earnings: 6929's earnings are forecast to grow, but not significantly.
Revenue vs Market: 6929's revenue (12.7% per year) is forecast to grow faster than the Hong Kong market (8.1% per year).
High Growth Revenue: 6929's revenue (12.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 6929's Return on Equity is forecast to be low in 3 years time (10.6%).